Observational studyBMC cancer2025

Abemaciclib in combination with endocrine therapy for the treatment of HR-positive/HER2-negative locally advanced/metastatic breast cancer in the UK: an observational study.

Judy King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.